← back to search

Yuanxiang Wang

Shihezi University · CN
Area of research
Molecular Biology · Surgery
Research interest
Research interests include Congenital Diaphragmatic Hernia Studies, Chemical Synthesis and Analysis, Cancer-related gene regulation, and Epigenetics and DNA Methylation.
h-index
30
citations
2,940
works
147
NIH funding
primary concept
email

Recent publications

Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer
Cancer Letters 2023cited by 83position: middledoi
Targeting Arginine Methyltransferase PRMT5 for Cancer Therapy: Updated Progress and Novel Strategies
Journal of Medicinal Chemistry 2023cited by 70position: lastdoi
Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer
Redox Biology 2022cited by 480position: middledoi
The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts
Acta Pharmacologica Sinica 2021cited by 35position: middledoi
A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance
Theranostics 2020cited by 109position: middledoi
Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?
European Journal of Medicinal Chemistry 2019cited by 85position: lastdoi
Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery
Journal of Medicinal Chemistry 2018cited by 100position: firstdoi
In Vitro Pharmacokinetic Optimizations of AM2-S31N Channel Blockers Led to the Discovery of Slow-Binding Inhibitors with Potent Antiviral Activity against Drug-Resistant Influenza A Viruses
Journal of Medicinal Chemistry 2018cited by 52position: firstdoi
Structure–Property Relationship Studies of Influenza A Virus AM2-S31N Proton Channel Blockers
ACS Medicinal Chemistry Letters 2018cited by 36position: middledoi
Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance
Scientific Reports 2018cited by 34position: middledoi
Selective N-terminal functionalization of native peptides and proteins
Chemical Science 2017cited by 150position: middledoi
Expeditious Lead Optimization of Isoxazole-Containing Influenza A Virus M2-S31N Inhibitors Using the Suzuki–Miyaura Cross-Coupling Reaction
Journal of Medicinal Chemistry 2017cited by 72position: middledoi
Application of Thiol–yne/Thiol–ene Reactions for Peptide and Protein Macrocyclizations
Chemistry - A European Journal 2017cited by 54position: firstdoi
Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses
European Journal of Medicinal Chemistry 2017cited by 34position: middledoi
Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel
ACS Infectious Diseases 2016cited by 40position: middledoi
A Thiol–Ene Coupling Approach to Native Peptide Stapling and Macrocyclization
Angewandte Chemie International Edition 2015cited by 186position: firstdoi
A Thiol–Ene Coupling Approach to Native Peptide Stapling and Macrocyclization
Angewandte Chemie 2015cited by 134position: firstdoi
Metal-free, efficient hydrazination of imidazo[1,2-a]pyridine with diethyl azodicarboxylate in neutral media
Organic & Biomolecular Chemistry 2015cited by 38position: firstdoi
Efficient Access to 2,3-Diarylimidazo[1,2-<i>a</i>]pyridines via a One-Pot, Ligand-Free, Palladium-Catalyzed Three-Component Reaction under Microwave Irradiation
Organic Letters 2014cited by 63position: firstdoi
Targeting Mutant KRAS for Anticancer Therapeutics: A Review of Novel Small Molecule Modulators
Journal of Medicinal Chemistry 2013cited by 118position: firstdoi
A p-toluenesulfinic acid-catalyzed three-component Ugi-type reaction and its application for the synthesis of α-amino amides and amidines
Tetrahedron Letters 2013cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jun Wang · University of Science and Technology Liaoning6 papers (2016–2018)Yanmei Hu · Kyushu University6 papers (2016–2018)Chunlong Ma · University of Arizona6 papers (2016–2018)Xiaolei Zhang · Guangdong Pharmaceutical University5 papers (2019–2023)Shumin Ouyang · Guangdong Pharmaceutical University4 papers (2020–2023)Brendan Frett · University of Arizona4 papers (2013–2015)Hongyu Li · Guiyang Medical University4 papers (2013–2015)Kai Zhu · Fudan University4 papers (2019–2022)Danny Hung‐Chieh Chou · Palo Alto University4 papers (2015–2017) · 3 papers (2019–2021)Shuting Xu · Institute of Bioorganic Chemistry3 papers (2018–2018)Shuo Shi · Harbin University of Science and Technology3 papers (2019–2021)Jianshan Mo · Guangdong Pharmaceutical University3 papers (2020–2022)Qiuyao Huang · Sun Yat-sen University3 papers (2019–2022)Raymond K. Hau · University of Arizona2 papers (2018–2018)Wenhao Hu · Sun Yat-sen University2 papers (2019–2020)Wen Ding · Sun Yat-sen University2 papers (2022–2023)Peibin Yue · Cedars-Sinai Medical Center2 papers (2022–2023)Fang Li · Qinghai University2 papers (2016–2017)Yongtao Zhang · Shenzhen University2 papers (2018–2018)